Clinical Immunotherapeutics

, Volume 2, Issue 2, pp 84–88 | Cite as

Immune Function in Chronic Fatigue Syndrome and Depression

Implications for Understanding these Disorders and for Therapy
  • Andrew Lloyd
  • Ian Hickie
  • Andrew Wilson
  • Denis Wakefield
Leading Article

Summary

Considerable data now support the concept that patients with chronic fatigue syndrome and those with the melancholic subtype of major depression frequently have alterations in measures of immune function in vitro and in vivo. Although chronic fatigue syndrome and major depression have significant clinical similarity, the patterns of immunological and neuroendocrine alterations seen in the 2 disorders are dissimilar. The immunological changes provide tantalising clues to the pathophysiology of these disorders but, as yet, do not have clear implications for therapy.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Lloyd A, Wakefield D, Dwyer J, et al. What is myalgic encephalomyelitis? Lancet 1988; 1: 1286–7PubMedCrossRefGoogle Scholar
  2. 2.
    Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988; 108: 387–9PubMedGoogle Scholar
  3. 3.
    Sharpe MC, Archard LC, Banatvala JE, et al. A report — chronic fatigue syndrome: guidelines for research. J R Soc Med 1991; 84: 118–21PubMedGoogle Scholar
  4. 4.
    Lloyd AR, Hickie I, Boughton CR, et al. The prevalence of chronic fatigue syndrome in an Australian population. Med J Aust 1990; 153: 522–8PubMedGoogle Scholar
  5. 5.
    Cox B, Blaxter M, Buckle A, et al. The health and lifestyles survey. London: Health Promotion Research Trust, 1987Google Scholar
  6. 6.
    Chen MK. The epidemiology of self perceived fatigue among adults. Prev Med 1986; 15: 74–81PubMedCrossRefGoogle Scholar
  7. 7.
    David A, Pelosi A, McDonald E, et al. Tired, weak, or in need of rest: fatigue among general practice attenders. BMJ 1990; 301: 1199–202PubMedCrossRefGoogle Scholar
  8. 8.
    Harvard C. Lassitude. BMJ 1985; 290: 1161–2CrossRefGoogle Scholar
  9. 9.
    Kroenke K, Wood DR, Mangelsdorff AD, et al. Chronic fatigue in primary care: prevalence, patient characteristics and outcome. JAMA 1988; 260: 929–34PubMedCrossRefGoogle Scholar
  10. 10.
    Hickie I, Lloyd A, Wakefield D, et al. The psychiatric status of patients with chronic fatigue syndrome. Br J Psychiatry 1990; 156: 534–40PubMedCrossRefGoogle Scholar
  11. 11.
    Taerk GS, Toner BB, Salit IE, et al. Depression in patients with neuromyasthenia (benign myalgic encephalomyelitis). Int J Psychiatry Med 1987; 17: 49–56PubMedCrossRefGoogle Scholar
  12. 12.
    Wessely S, Powell R. Fatigue syndromes: a comparison of chronic ‘postviral’ fatigue with neuromuscular and affective disorders. J Neurol Neurosurg Psychiatry 1989; 52: 940–8PubMedCrossRefGoogle Scholar
  13. 13.
    Kruesi MJP, Dale J, Straus SE. Psychiatric diagnoses in patients who have chronic fatigue syndrome. J Clin Psychiatry 1989; 50: 53–6PubMedGoogle Scholar
  14. 14.
    Katon WJ, Buchwald DS, Simon GE, et al. Psychiatric illness in patients with chronic fatigue and those with rheumatoid arthritis. J Gen Intern Med 1991; 6: 277–85PubMedCrossRefGoogle Scholar
  15. 15.
    Lloyd AR, Wakefield D, Hickie I. Immunity and the pathophysiology of chronic fatigue syndrome. Ciba Found Symp 1993; 173: 176–92PubMedGoogle Scholar
  16. 16.
    Wakefield D, Lloyd AR. The pathophysiology of myalgic encephalomyelitis. Lancet 1987; 2: 918–9PubMedCrossRefGoogle Scholar
  17. 17.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd rev. ed. Washington DC: American Psychiatric Association, 1987Google Scholar
  18. 18.
    Kiloh LG, Andrews G, Neilsen M, et al. The relationship of the syndromes called endogenous and neurotic depression. Br J Psychiatry 1972; 121: 183–96PubMedCrossRefGoogle Scholar
  19. 19.
    Hickie I, Hickie C, Silove D, et al. Is there significant immune dysfunction in depressive disorders? Psychol Med 1990; 20: 755–61PubMedCrossRefGoogle Scholar
  20. 20.
    Stein M, Miller AH, Trestman RL. Depression, the immune system, and health and illness. Arch Gen Psychiatry 1991; 48: 171–7PubMedCrossRefGoogle Scholar
  21. 21.
    Hickie I, Hickie C, Lloyd A, et al. Impaired cell-mediated immunity in melancholia. Br J Psychiatry 1993; 157: 65–71CrossRefGoogle Scholar
  22. 22.
    Lloyd A, Hickie I, Hickie C, et al. Cell-mediated immunity in patients with chronic fatigue syndrome, healthy control subjects and patients with major depression. Clin Exp Immunol 1992; 87: 76–9PubMedCrossRefGoogle Scholar
  23. 23.
    Carrol BJ, Feinberg M, Greden JF, et al. A specific laboratory test for the diagnosis of melancholia: standardization, validation and clinical utility. Arch Gen Psychiatry 1981; 38: 15–22CrossRefGoogle Scholar
  24. 24.
    Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 1224–34PubMedCrossRefGoogle Scholar
  25. 25.
    Bakheit AM, Behan PO, Dinan TG, et al. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ 1992; 304: 1010–2PubMedCrossRefGoogle Scholar
  26. 26.
    Lopez-Ibor JJ. The involvement of serotonin in psychiatric disorders and behaviour. Br J Psychiatry 1988; 153 Suppl. 3: 26–9Google Scholar
  27. 27.
    Rivier C, Rivest S. Mechanisms mediating the effects of cytokines on neuroendocrine functions in the rat. Ciba Found Symp 1993; 172: 204–25PubMedGoogle Scholar
  28. 28.
    Lloyd A, Hickie I, Wakefield D, et al. A double-blind, placebo-controlled trial of intravenous immunoglobulin therapy in patients with the chronic fatigue syndrome. Am J Med 1990; 89: 561–8PubMedCrossRefGoogle Scholar
  29. 29.
    Cappel R, Gregoire F, Thiry L, et al. Antibody and cell-mediated immunity to herpes simplex virus in psychotic depression. J Clin Psychiatry 1978; 39: 266–8PubMedGoogle Scholar
  30. 30.
    Levine P, Peterson D, McNamee F, et al. Does chronic fatigue syndrome predispose to non-Hodgkin’s lymphoma? Cancer Res 1992; Suppl 52: 5516–8Google Scholar
  31. 31.
    Kendler KS. A twin study of mortality in schizophrenia and neurosis. Arch Gen Psychiatry 1986; 43: 643–9PubMedCrossRefGoogle Scholar
  32. 32.
    Murphy JM, Monson RR, Olivier DC, et al. Mortality risk and psychiatric disorders: results of a general physician survey. Social Psychiatry 1989; 24: 134–42Google Scholar
  33. 33.
    Bruce ML, Leaf PJ. Psychiatric disorders and 15-month mortality in a community sample of older adults. Am J Public Health 1989; 79: 727–30PubMedCrossRefGoogle Scholar
  34. 34.
    Lloyd A, Hickie I, Brockman A, et al. Immunological and psychological therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med 1993; 94: 197–203PubMedCrossRefGoogle Scholar
  35. 35.
    Petersen PK, Shepard J, Macres M, et al. A controlled trial of intravenous immunoglobulin G in chronic fatigue syndrome. Am J Med 1990; 89: 554–60CrossRefGoogle Scholar
  36. 36.
    Gutterman J. Overview of advances in the uses of biological proteins in human cancer. Semin Oncol 1988; 15 Suppl. 5: 2–6PubMedGoogle Scholar
  37. 37.
    McDonald EM, Mann AH, Thomas HC. Interferons as mediators of psychiatric morbidity: an investigation in a trial of recombinant alpha interferon in hepatitis B carriers. Lancet 1987; 2: 1175–9PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1994

Authors and Affiliations

  • Andrew Lloyd
    • 1
    • 2
    • 3
  • Ian Hickie
    • 4
    • 5
  • Andrew Wilson
    • 4
    • 5
  • Denis Wakefield
    • 2
    • 3
  1. 1.Department of Infectious Diseases, Division of MedicineThe Prince Henry HospitalLittle BayAustralia
  2. 2.Department of Immunopathology, Division of PathologyThe Prince Henry HospitalLittle BayAustralia
  3. 3.Inflammatory Diseases Unit, School of PathologyThe University of New South WalesSydneyAustralia
  4. 4.The Mood Disorders Unit, Division of PsychiatryThe Prince Henry HospitalLittle BayAustralia
  5. 5.School of PsychiatryThe University of New South WalesSydneyAustralia

Personalised recommendations